T. Lüscher in conversation with S. Goldhaber and M. Cushman: ADOPT- Extended Anticoagulant Prophylaxis in Initially Hospitalized Medically Ill Patients: Results of the ADOPT Trial
T. Lüscher in conversation with J. Spertus and M. Patel: PRISM- Testing an Evidence-Based, Individualized Informed Consent Form to Improve Patients' Experiences with PCI
William Hiatt in conversation with Ulf Landmesser
NV1FGF Gene Therapy on Amputation-Free Survival in Critical Lib Ischemia – Phase 3 Randomized Double-Blind Placebo-Controlled Trial
Murray Esler in conversation with Thomas Lüscher
Symplicity HTM-2: International, Multicenter, Prospective, Randomized, Controlled Trial of Endovascular Selective Renal Sympathetic Denervation for the Treatment of Hypertension
Ron Peters in conversation with Ulf Landmesser
RESPONSE: Effect of a nurse coordinated prevention program on cardiovascular risk after an acute coronary syndrome: Main results of the RESPONSE trial.
Sanjit Jolly in conversation with Thomas Lüscher
FUTURA OASIS 8 : A randomised trial comparing two regimens of adjunctive intravenous unfractionated heparin during PCI in high-risk patients with non-STE-ACS treated with fondaparinux.
Jens Nielsen In conversation with Thomas Lüscher
DANPACE: The Danish multicentre randomised trial on single lead atrial versus dual chamber pacing in sick sinus syndrome.
